Health Condition 1: I838- Varicose veins of lower extremities with other complications
Conditions
Interventions
Intervention1: N butyl cyanoacrylate: N butyl cyanoacrylate is a liquid embolic agent used percutaneously to occlude varicose vein perforators.
Dose- N butyl cyanoacrylate glue small volume (0.1 to 0.
Sponsors
Dr Lalit Nirwan
Eligibility
Inclusion criteria
Inclusion criteria: Patient of lower limb varicose veins previously treated with any modality. Patient who have recurrent perforator identified on Ultrasound. Patient willing to sign informed consent and participate in study.
Exclusion criteria
Exclusion criteria: Patients with Deep venous thrombosis. Pregnant and lactating women. Undiagnosed cause of recurrence of varicose veins. Any patient with terminal illness such as cancer. Any other condition that in the view of Principal Investigator demands exclusion from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of closure rates of recurrent perforators Improvements in symptoms Complications Timepoint: 6 wks | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome Improvement in Symptoms To evaluate the improvement in symptoms associated with varicose veins due to recurrent perforator following closure using cyanoacrylate glue at 6 wks Recurrence rate To assess the rate of perforator recurrence post cyanoacrylate glue closure in cases with recurrent perforators treated with glue at 6 wks Adverse Events To document & evaluate any adverse events associated with cyanoacrylate glue closureTimepoint: 6 wks | — |
Countries
India
Contacts
Public ContactDr Lalit Nirwan
Datta Meghe Hospital
Outcome results
None listed